Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
28/03/2026
Tehran's northeast region hit by airstrikes again.
Latest
12 m ago
Saudi Arabia: Intercepts two drones in the past few hours.
12 m ago
The "Online Sales Product Quality and Safety Enhancement Series Action 2026" was launched in Beijing.
13 m ago
Standard Stock: Strategic cooperation with Ankang College and Shaanxi Textile Industry Association.
16 m ago
Iran claims that drones have carried out a large-scale attack on Israeli targets.
16 m ago
According to the AI Fast News of Every Macro, Dongwu Securities issued a research report on March 28, giving Lijiu Group (000513.SZ) a "buy" rating. The rating reasons mainly include: 1) the biological products, traditional Chinese medicine sector, and overseas growth rate are good by 2025, and the overall performance meets expectations; 2) the layout of innovative drugs and biopharmaceutical pipeline is accelerating, with single products worth more than 1 billion yuan being listed one after another. (Daily Economic News)
See all latest